Figure 1.

Photomicrograh 200×. A) Lymph node B) visceral and C) subcutaenous metastases in patients with cutaneous melanoma showing intense immunostaining (brown spots). D) Lymph node, E) subcutaneous and F) visceral mestastases in patients with cutaneous melanoma showing weak expression of bcl-2 protein. Absence of bcl-2 expression in G) lymph node H) subcutaneous melanoma and I) visceral melanoma metastases.